Lake Bluff, IL, United States of America

John W Kebabian


Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 1990-1992

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of John W Kebabian

Introduction

John W Kebabian is a notable inventor based in Lake Bluff, IL (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target dopamine receptors. With a total of 3 patents to his name, Kebabian's work has implications for treating various neurological and psychological disorders.

Latest Patents

Kebabian's latest patents include groundbreaking research on tetracyclic spirobenzazepine dopamine antagonists. These novel compounds are designed to treat dopamine-related neurological and psychological disorders, cognitive impairment, attention deficit disorders, and addictive behavior disorders. Another significant patent involves dopaminergic compounds, which are formulated to enhance the efficacy of treatments targeting dopamine receptors.

Career Highlights

Throughout his career, Kebabian has been associated with Abbott Laboratories Corporation, a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic applications, showcasing his commitment to improving patient outcomes.

Collaborations

Kebabian has collaborated with esteemed colleagues such as Robert W Schoenleber and Michael P DeNinno. These partnerships have fostered innovation and have been instrumental in the successful development of his patented compounds.

Conclusion

John W Kebabian's contributions to the field of pharmacology through his innovative patents highlight his role as a significant inventor. His work continues to influence the treatment of various disorders, showcasing the importance of research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…